2_800x533_L_1412520354.jpg)
- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
CSL Ltd (CSL)
The CSL share price today is 157.82, view ASX CSL stock exchange data. Track the latest CSL share price with real-time updates on CSL stock performance including market cap, day range, 52-week range and dividend yield. Access CSL charts, earnings dates and analyst estimates to support your investment decisions.
157.82
+23.22(+17.25%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
148.41
159.25
52 wk Range
90.00
257.00
Unusual trading volume
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
148.41159.25
52 wk Range
90.00257.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.70%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(2.70%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
CSL Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
137.11
Downside
-13.12%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Trading at a high earnings multiple
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Analyst Ratings
7 Buy
9 Hold
0 Sell
Ratings:
16 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 137.11
(-13.12% Downside)
CSL Ltd Earnings Call Summary for H2/2026
- CSL reported FY26 revenue of $15.8B (down 1%) and underlying NPAT-A of $3.1B (down 2%); statutory loss of $2.6B due to $6B in restructuring charges.
- Shares surged 16.4% to $156.68 as company guided FY27 NPAT growth of ~5% despite flat revenue; authorized new AUD 1.1B buyback program.
- CSL Behring expected to return to mid-single-digit growth on strong immunoglobulin demand; Vifor remains major drag with ~25% revenue decline forecast.
- Company targeting $220M incremental savings in FY27, rising to $550M by FY28; maintaining dividend at $2.92/share with strong $3.5B operating cash flow.
- Seqirus forecast for low-single-digit growth despite soft U.S. flu market; management emphasized plasma efficiency and portfolio simplification as key priorities.
Last Updated: 18-08-2026, 06:58 am
Read Full TranscriptEarnings
Latest Release
18-08-2025
EPS / Forecast
2.04 / 2.70
Revenue / Forecast
7.08B / 10.2B
Compare CSL to Peers and Sector
Metrics to compare | CSL | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCSLPeersSector | |
|---|---|---|---|---|
P/E Ratio | 32.8x | 27.5x | −0.3x | |
PEG Ratio | −0.78 | 0.11 | 0.00 | |
Price/Book | 2.5x | 2.4x | 2.6x | |
Price / LTM Sales | 3.0x | 2.6x | 3.1x | |
Upside (Analyst Target) | −17.4% | 44.0% | 49.0% | |
Fair Value Upside | Unlock | 16.4% | 6.3% | Unlock |
CSL Limited engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment manufactures, markets, and distributes plasma products, gene therapies, and recombinants. This segment also offers therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. The CSL Seqirus segment manufactures, markets, and distributes influenza related products and pandemic services to governments. The CSL Vifor segment manufactures, markets, and distributes products in the therapeutic areas of iron deficiency and nephrology. It also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.
Ownership
Ownership Overview
Top Holders
FAQ
What Is the CSL (CSL) Share Price Today?
The CSL share price today is 157.82.
What is the current CSL (CSL) share price and day range?
As of 18-08-2026, the CSL share price is 157.82, with a previous close of 134.60. The share price has ranged from 148.41 to 159.25 today, while the 52-week range spans from 90.00 to 257.00.
What Is the CSL Market Cap?
As of today, CSL market cap is 64.46B.
Does CSL Pay Dividends? What's The Current Dividend Yield?
The CSL dividend yield is 2.7%.
What Is the CSL (CSL) Share Price Target?
The average 12-month share price target for CSL is 137.11, with a high estimate of 195.37605634 and a low estimate of 106.62535211. 7 analysts recommend buying, while 0 suggest selling, with an overall rating of Buy and -13.12% Downside potential.
What Is CSL's Earnings Per Share (TTM)?
The CSL EPS (TTM) is 2.86.
From a Technical Analysis Perspective, Is CSL a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
What Stock Exchange Does CSL Trade On?
CSL is listed and trades on the Sydney Stock Exchange.
What Is the Stock Symbol for CSL?
The stock symbol for CSL is "CSL."
How Many Times Has CSL Stock Split?
CSL has split 1 times.
How Many Employees Does CSL Have?
CSL has 29904 employees.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.